Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: A phase I clinical trial.
Andreone P, Catani L, Margini C, Brodosi L, Lorenzini S, Sollazzo D, Nicolini B, Giordano R, Montemurro T, Rizzi S, Dan E, Giudice V, Viganò M, Casadei A, Foschi FG, Malvi D, Bernardi M, Conti F, Lemoli RM.
Andreone P, et al. Among authors: nicolini b.
Dig Liver Dis. 2015 Dec;47(12):1059-66. doi: 10.1016/j.dld.2015.08.018. Epub 2015 Sep 10.
Dig Liver Dis. 2015.
PMID: 26427587
Clinical Trial.